Flynn P M, McCann J T, Fairbank J A
Center for Community-Based Treatment Research, Research Triangle Institute, Research Triangle Park, North Carolina 27709-2194, USA.
J Clin Psychol. 1995 May;51(3):415-21. doi: 10.1002/1097-4679(199505)51:3<415::aid-jclp2270510316>3.0.co;2-6.
Substance abuse treatment clients often present other severe mental health problems that affect treatment outcomes. Hence, screening and assessment for psychological distress and personality disorder are an important part of effective treatment, discharge, and aftercare planning. The Millon Clinical Multiaxial Inventory-II (MCMI-II) frequently is used for this purpose. In this paper, several issues of concern to MCMI-II users are addressed. These include the extent to which MCMI-II scales correspond to DSM-III-R disorders; overdiagnosis of disorders using the MCMI-II; accuracy of MCMI-II diagnostic cut-off scores; and the clinical utility of MCMI-II diagnostic algorithms. Approaches to addressing these issues are offered.
药物滥用治疗患者常常还存在其他严重的心理健康问题，这些问题会影响治疗效果。因此，对心理困扰和人格障碍进行筛查与评估是有效治疗、出院计划及后续护理计划的重要组成部分。米隆临床多轴问卷第二版（MCMI-II）经常用于这一目的。本文讨论了MCMI-II使用者关心的几个问题。这些问题包括MCMI-II量表与《精神疾病诊断与统计手册》第三版修订本（DSM-III-R）中疾病的对应程度；使用MCMI-II对疾病的过度诊断；MCMI-II诊断临界值分数的准确性；以及MCMI-II诊断算法的临床实用性。文中还提供了解决这些问题的方法。
